Novel hydantoin derivatives as metalloproteinase inhibitors

Details for Australian Patent Application No. 2005317286 (hide)

Owner AstraZeneca AB

Inventors Shamovsky, Igor; Gabos, Balint; Zlatoidsky, Pavol; Munck Af Rosenschold, Magnus; Lundkvist, Michael

Agent Freehills

Pub. Number AU-B-2005317286

PCT Pub. Number WO2006/065215

Priority 0403085-4 17.12.04 SE

Filing date 14 December 2005

Wipo publication date 22 June 2006

Acceptance publication date 5 February 2009

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/444 (2006.01)

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 35/00 (2006.01) Antineoplastic agents

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

21 June 2007 PCT application entered the National Phase

  PCT publication WO2006/065215 Priority application(s): WO2006/065215

5 February 2009 Application Accepted

  Published as AU-B-2005317286

4 June 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005317287-Novel hydantoin derivatives as metalloproteinase inhibitors

2005317285-Tri (hydroxymethyl) methylamine salt or an ethanol amine salt of (2S) - 2-ethoxy-3- (4-{2- [hexyl (2phenylethyl) amino] - 2 -oxoethoxy} phenyl) propanoic acid